Christopher Anderson, a Managing Director with StoneTurn, serves as a testifying and consulting financial expert in intellectual property and other complex disputes and in licensing negotiations. He has more than 15 years of experience consulting with clients and counsel regarding intellectual property matters in connection with economic damages disputes and licensing negotiations.
Prior to joining StoneTurn, Chris spent eight years in both financial and research positions primarily within the healthcare industry. He helped a top-ranked academic medical center analyze the financial, operational, and clinical impacts of offering new medical technologies. He also spent over two years with two international consulting firms where he concentrated on medical device intellectual property infringement.
Chris has assisted clients with engagements involving patent infringement, Lanham Act violations, misappropriation of trade secrets, copyright infringement, securities, breach of fiduciary duty, fraud and breach of contract. He has handled a number of matters involving multiple defendants, related plaintiffs and counter-claims. Further, he has been heavily involved in preparing clients for trial, including the preparation of direct and cross examinations, trial exhibits and demonstratives.
Chris has also worked closely with clients engaged in intellectual property licensing negotiations to analyze the economics and communicate the implications to potential licensees. In addition to his financial and economic experience, Chris also served as a clinical monitor and a study coordinator on Phase I and II clinical trials for two contract research organizations.